MA42889B2 - Triple activator activating the glucagon, glp-1 and gip receptor - Google Patents
Triple activator activating the glucagon, glp-1 and gip receptorInfo
- Publication number
- MA42889B2 MA42889B2 MA42889A MA42889A MA42889B2 MA 42889 B2 MA42889 B2 MA 42889B2 MA 42889 A MA42889 A MA 42889A MA 42889 A MA42889 A MA 42889A MA 42889 B2 MA42889 B2 MA 42889B2
- Authority
- MA
- Morocco
- Prior art keywords
- glp
- glucagon
- gip receptor
- triple activator
- activator activating
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
La présente invention concerne un triple activateur qui active le récepteur du glucagon, du glp-1 et du gip, et des applications de ce triple activateur.The present invention relates to a triple activator which activates the receptor for glucagon, glp-1 and gip, and applications of this triple activator.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20150191082 | 2015-12-31 | ||
PCT/KR2016/015554 WO2017116204A1 (en) | 2015-12-31 | 2016-12-30 | Triple activator activating glucagon, glp-1 and gip receptor |
Publications (2)
Publication Number | Publication Date |
---|---|
MA42889A1 MA42889A1 (en) | 2018-11-30 |
MA42889B2 true MA42889B2 (en) | 2020-11-30 |
Family
ID=62104015
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA42889A MA42889B2 (en) | 2015-12-31 | 2016-12-30 | Triple activator activating the glucagon, glp-1 and gip receptor |
MA42891A MA42891B2 (en) | 2015-12-31 | 2016-12-30 | Persistent conjugate of a triple activator activating the glucagon, glp-1 and gip receptor |
MA51955A MA51955B1 (en) | 2015-12-31 | 2016-12-30 | Triple activator activating glucagon, glp-1 and gip receptor |
MA53533A MA53533A1 (en) | 2015-12-31 | 2018-07-26 | Persistent conjugate of a triple activator activating the glucagon, glp-1 and gip receptor |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA42891A MA42891B2 (en) | 2015-12-31 | 2016-12-30 | Persistent conjugate of a triple activator activating the glucagon, glp-1 and gip receptor |
MA51955A MA51955B1 (en) | 2015-12-31 | 2016-12-30 | Triple activator activating glucagon, glp-1 and gip receptor |
MA53533A MA53533A1 (en) | 2015-12-31 | 2018-07-26 | Persistent conjugate of a triple activator activating the glucagon, glp-1 and gip receptor |
Country Status (3)
Country | Link |
---|---|
AR (2) | AR107282A1 (en) |
MA (4) | MA42889B2 (en) |
MY (1) | MY199261A (en) |
-
2016
- 2016-12-30 MY MYPI2018001199A patent/MY199261A/en unknown
- 2016-12-30 MA MA42889A patent/MA42889B2/en unknown
- 2016-12-30 MA MA42891A patent/MA42891B2/en unknown
- 2016-12-30 MA MA51955A patent/MA51955B1/en unknown
-
2017
- 2017-01-02 AR ARP170100004A patent/AR107282A1/en unknown
- 2017-01-02 AR ARP170100003A patent/AR107281A1/en unknown
-
2018
- 2018-07-26 MA MA53533A patent/MA53533A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
MA42891B2 (en) | 2021-11-30 |
MA51955A1 (en) | 2021-10-29 |
MY199261A (en) | 2023-10-23 |
MA53533A1 (en) | 2022-08-31 |
AR107281A1 (en) | 2018-04-18 |
AR107282A1 (en) | 2018-04-18 |
MA42891A1 (en) | 2019-04-30 |
MA42889A1 (en) | 2018-11-30 |
MA51955B1 (en) | 2022-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12018501409A1 (en) | Triple glucagon/glp-1/gip receptor agonist | |
MX2020009649A (en) | Monoclonal antibodies against bcma. | |
MA49545B1 (en) | Glucagon derivative and composition comprising a long-acting conjugate thereof | |
MX2018006148A (en) | Inhibitors of cxcr2. | |
PE20180395A1 (en) | SOLID DOSAGE FORMS OF PALBOCICLIB | |
MX2020003217A (en) | Long-acting co-agonists of the glucagon and glp-1 receptors. | |
EA201792612A1 (en) | 6-AMINOHINOLIN-3-CARBONITRILES AS COT MODULATORS | |
CL2019003599S1 (en) | Extinguisher. | |
WO2017074798A3 (en) | Long-acting co-agonists of the glucagon and glp-1 receptors | |
EA201890828A1 (en) | OPTIMIZED TABLET WITH HIGH DOSE OF ACTIVE COMPOUND, CONTAINING MESALAZIN | |
TR201901228T4 (en) | Vortioxetine pyroglutamate. | |
EA201792527A1 (en) | TREATMENT OF ZUD | |
MA42889B2 (en) | Triple activator activating the glucagon, glp-1 and gip receptor | |
ECSP17085737A (en) | SOLID DOSAGE FORMS OF PALBOCICLIB | |
EA201991993A1 (en) | APPLICATION OF PHENYLCREATIN AS A NOOTROPIC AGENT | |
CL2015000874A1 (en) | Pde9i with main structure of imidazopirazinone | |
UA104671U (en) | Application of iakton as neuroprotective agents. | |
UA101750U (en) | Use of omega as organoprotector in toxic hepatitis | |
TN2014000522A1 (en) | لوح مدرسي بوجهين | |
UA100710U (en) | APPLICATION OF FITOVENOL Capsules AS A HEPATOPROTECTOR | |
TN2014000377A1 (en) | طائرة كهربائية كاتمة للصوت |